Panleucogating as an accurate and affordable flow cytometric protocol to analyse lymphocyte subsets among HIV-positive patients on HAART treatment in Mozambique

Journal of Biological Regulators and Homeostatic Agents

Volumn 19, Issue 3-4, 2005, Pages 169-175

  Ceffa, Susanna ^a,c   Erba, F ^b   Assane, M ^c   Coelho, E ^d   Calgaro, M ^c   Brando, B ^e  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c DREAM Program Community of Sant' Egidio   (Italy)

^d Ministry of Health   (Italy)

^e Ospedale Civile di Legnano   (Italy)

Author keywords

CD4; HIV AIDS; Panleucogating; Resource poor settings

Indexed keywords

ANTIRETROVIRUS AGENT; CD3 ANTIGEN; CD4 ANTIBODY; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;

ACCURACY; ARTICLE; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATION FUNCTION; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MOZAMBIQUE; PROCESS OPTIMIZATION; RELIABILITY; T LYMPHOCYTE SUBPOPULATION; COMPARATIVE STUDY; COST; ECONOMICS; EVALUATION; IMMUNOLOGY; METHODOLOGY; STATISTICS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-CD8 RATIO; COSTS AND COST ANALYSIS; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; INDICATORS AND REAGENTS; MOZAMBIQUE;

EID: 33744522929     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. UNAIDS 2004 Report on the global AIDS epidemic. 11-16 July, XV International AIDS Conference Bangkok.
2. De Luca A, Gialloreti Emberti L, Vella S, Abdel Magid N, Palombi L. Efficacy of free HAART in HIV1 infected subjects in Mozambique. 13th ICASA Nairobi, 22-25 September 2003. Abstract book: pp. 157-78.
3. Emberti Gialloreti L, De Luca A, Perna CF, et al. Increase in survival in HIV1 infected subjects in Matola, Mozambique after the introduction of combination therapy with generic-manufactured antiretrovirals. 10th Conference on Retroviruses and Opportunistic Infections. Boston USA, 10-14 February 2003. Abstract book: p. 122.
4. CSE - Community of Sant'Egidio. DREAM Drug Resources Enhancement against AIDS and Malnutrition. Internal Report n. 2, pag. 1, Nov. 2004.
5. WHO Scaling up antiretroviral therapy in limited-resource settings. Guidelines for a public health approach. Geneva 2002.
6. Spacek LA Griswold M, Quinn TC, Moore RD. Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource limited settings. AIDS 2003; 17: 1311-7.
7. Badri M, Wood R. Usefulness of total lymphocyte count in monitoring highly active therapy in resource-limited-setting. AIDS 2003; 17: 541-5.
8. Liotta G, Perno CF, Ceffa S, et al. Is total lymphocyte count a reliable predictor of the CD4 lymphocyte cell count in resource-limited settings? AIDS 2004; 18: 1082-3.
9. Mandy FF. Twenty five years of clinical flow cytometry: AIDS accellerated global instrument distribution. Cytometry 2004; 58: 55-6.
10. MMWR. Guidelines for performing single platform absolute CD4+ T-cell with CD45 gating for persons infected with HIV. Recomm Rep 2003; 52: 1-13.
11. Bi X, Gatanaga H, Tanaka M. Modified dynabeads method for enumerating CD4+ T lymphocytes count for widespread use in resource-limited situations. J Acquir Immune Defic Syndr 2005; 38: 1-4.
12. Cassens U, Gohde W, Kuling G, et al. Simplified volumetric flow cytometry allows feasible and accurate determination of CD4 T lymphocytes in immunodeficient patients worldwide. Antivir Ther 2004; 9: 395-405.
13. Diagbouga S, Chazallon C, Kazatchkine MD, et al. Successful implementation of a low-cost method for enumerating CD4+ T lymphocytes in resource-limited settings: The ANRS 12-26 study. AIDS 2003; 17: 2201-8.
14. Diagbouga S, Durand G, Sanou PT, Dahourou H, Ledru E. Evaluation of a quantitative determination of CD4 and CD8 molecules as an alternative to CD4+ and CD8+ T lymphocyte counts in Africans. Trop Med Int Health 1999; 4: 79-84.
15. Gelman R, Wilkening C. Analyses of quality assessment studies using CD45 for gating lymphocytes for CD3+4+%. Cytometry 2000; 42: 1-4.
16. Glencross D, Scott L, Aggett H, Sonday S, Scott CS. Microvolume fluorimetry for the determination of absolute CD4 and CD8 lymphocyte counts in patients with HIV: A comparative evaluation. Clin Lab Haematol 1999; 21: 391-5.
17. Gomo E, Ndhlovu P, Vennervald BJ, Nyazema N, Friis H. Enumeration of CD4 and CD8 T-cells in HIV infection in Zimbabwe using a manual immunocytochemical method. Cent Afr J Med 2001; 47: 64-70.
18. Mwaba P, Cassol S, Pilon R. Use of dried whole blood spots to measure CD4+ lymphocyte counts in HIV-1-infected patients. Lancet 2003; 362: 1459-60.
19. Pattanapanyasat K, Shain H, Noulsri E, et al. A multicenter evaluation of the panleucogating method and the use of generic monoclonal antibody reagents for CD4 enumeration in HIV-infected patients in Thailand. Cytometry Part B (Clinical Cytometry) 2005; 65B: 29-36.
20. Balakrishnan P, Dunne M, Kumarasamy N. An inexpensive, simple, and manual method of CD4 T-cell quantitation in HIV-infected individuals for use in developing countries. J Acquir Immune Defic Syndr 2004; 36: 1006-10.
21. Hengel RL, Nicholson JK. An update on the use of flow cytometry in HIV infection and AIDS. Clin Lab Med 2001; 21: 841-56.
22. Mandy F, Nicholson J, Autran B, Janossy G. T-cell subset counting and the fight against AIDS: Reflections over a 20-year struggle. Cytometry 2002; 50: 39-45.
23. Janossy G, Jani I, Bradley N, Bikoue A, Pitfield T, Glengross DK. Affordable CD4+ T-cell counting by flow cytometry: CD45 gating for volumetric analysis. Clin Diag Lab Immunol 2002; 9: 1085-94.
24. Janossy G, Jani IV, Brando B. New trends in affordable CD4+ T-cell enumeration by flow cytometry in HIV/AIDS. Clin and Appl Immunol Reviews 2003; 4: 91-107.
25. Janossy G, Jani IV, Kahan M, Barnett D, Mandy F, Shapiro H. Precise CD4 T-cell counting using red diode laser excitation: For richer, for poorer. Cytometry - Clinical Cytometry 2002; 50: 78-85.
26. Glencross D, Scott LE, Jani IV, Barnett D, Janossy G. CD45-assisted panleucogating for accurate, cost-effective dual-platform CD4 T-cell enumeration. Cytometry - Clinical Cytometry 2002; 50: 69-77.
27. Chan CW, Cheng LS, Ohan WK, Wong KH. Highly active antiretroviral therapy per se decreased mortality and morbidity of advanced human immunodeficiency virus disease in Hong Kong. Chin Med J (Engl) 2005; 118: 1338-45.
28. Jani IV, Janossy G, Iqbal A. Affordable CD4+ T cell counts by flow cytometry. II The use of fixed whole blood in resource poor settings. J Immunol Methods 2001; 257: 145-54.
29. Lau LG, Tan GB, Kuperan P. CD4 lymphocyte enumeration in patients with human immunodeficiency virus infection using three-colour and four-colour dual-platform flow cytometry: An inter-laboratory comparative evaluation. Ann Acad Med Singapore 2002; 31: 765-71.
30. Sherman GG, Galpin JS, Patel JM, Mendelow BV, Glencross DK. CD4+ T cell enumeration in HIV infection with limited resources J Immunol Methods 1999; 222: 209-17.
31. Chianese R, Nebuloni E, De Paschale M, Gatti A, Mena M. Absolute TCD4+ counting by a minimalist dual-platform flow cytometric method. J Biol Regul Homeost Agents 2003; 17: 358-65.